ICCC Insider Trading Activity and SEC Form 4 Filings
ICCC insider trading summary
Over the past 12 months, insiders at Immucell Corp (ICCC) reported 6 open-market purchases worth $140K by 2 insiders and no sales on SEC Form 4. Net insider buying was $140K.
Latest ICCC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | $76K (8,000 @ $9.49) |
| Dec 3, 2025 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | $18K (3,521 @ $5.04) |
| Dec 3, 2025 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | $13K (2,556 @ $5.00) |
| Dec 2, 2025 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | $18K (3,708 @ $4.87) |
| Nov 25, 2025 | David Scott Tomsche | Director | Buy | $8K (1,633 @ $4.76) |
| Nov 25, 2025 | David Scott Tomsche | Director | Buy | $8K (1,633 @ $4.76) |
| Jun 12, 2025 | Bryan K. Gathagan | Insider | Buy | $6K (1,000 @ $6.32) |
| Jun 13, 2022 | David Cunningham | Insider | Buy | $8K (1,000 @ $8.00) |
| Mar 12, 2020 | David Cunningham | Insider | Buy | $8K (2,000 @ $4.00) |
| Mar 11, 2020 | David Scott Tomsche | Insider | Buy | $20K (4,600 @ $4.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.